Mary Theresa Coelho
CIK 1720772 · EVP and CFO · last filed 2026-07-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$373.0K
Companies
7
Total Filings
24
Lifetime Open-Market Net
-$23.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Inotiv, Inc. (NOTV) Delisted | Director | 0 | $0.08 | $0 | -$12.9K | 5 | 2026-07-20 |
| HOOKIPA Pharma Inc. (HOOK) Delisted | EVP and CFO | 56,266 | $1.15 | $64.7K | -$12.5K | 4 | 2025-07-23 |
| GridAI Technologies Corp. (FWBI) Delisted | Director | 20,237 | $2.96 | $59.9K | $0 | 3 | 2024-01-04 |
| Gamida Cell Ltd. (GMDA) Delisted | Chief Financial Officer | — | $0.03 | — | $0 | 1 | 2023-06-14 |
| CinCor Pharma, Inc. (CINC) Delisted | EVP CFO & Chief BD Officer | 100 | $29.06 | $2.9K | $1.6K | 1 | 2022-01-13 |
| GridAI Technologies Corp. (AZRX) Delisted | Director | — | $3.45 | — | $0 | 1 | 2021-09-13 |
| BCPC | Chief Financial Officer | 2,105 | $177.19 | $373.0K | $0 | 2 | 2018-10-30 |
Recent Filings · Page 3 of 3
24 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-17 | — | Mixed | +12,018 | -$118.1K | |
| 2019-01-18 | — | Grant (A) | — | $0 | |
| 2018-10-30 | BCPC | Mixed | −1,187 | -$114.5K | EDGAR |
| 2018-02-20 | BCPC | Grant (A) | +1,260 | $0 | EDGAR |
Showing 21–24 of 24
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.